City State Bank’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8K Hold
111
– – 0.01% 396
2026
Q1
$27.8K Sell
111
-52
-32% -$12.9K 0.01% 423
2025
Q4
$44.8K Sell
163
-13
-7% -$3.56K 0.01% 364
2025
Q3
$46.2K Hold
176
– – 0.01% 351
2025
Q2
$38.5K Sell
176
-9
-5% -$1.92K 0.01% 364
2025
Q1
$41.4K Hold
185
– – 0.01% 362
2024
Q4
$60.6K Sell
185
-2
-1% -$629 0.02% 303
2024
Q3
$56.1K Hold
187
– – 0.02% 313
2024
Q2
$61.6K Hold
187
– – 0.03% 289
2024
Q1
$74K Sell
187
-4
-2% -$1.48K 0.03% 274
2023
Q4
$67K Hold
191
– – 0.03% 269
2023
Q3
$72K Sell
191
-23
-11% -$8.89K 0.04% 258
2023
Q2
$82K Sell
214
-51
-19% -$18.2K 0.04% 250
2023
Q1
$92K Sell
265
-17
-6% -$4.97K 0.05% 233
2022
Q4
$66K Hold
282
– – 0.04% 250
2022
Q3
$69K Hold
282
– – 0.05% 231
2022
Q2
$85K Sell
282
-17
-6% -$5.53K 0.06% 222
2022
Q1
$123K Sell
299
-14
-4% -$5.48K 0.07% 200
2021
Q4
$147K Buy
+313
New +$135K 0.09% 188

Other funds holding WST

City State Bank's WST Position: Q2 2026 in Review

City State Bank held its West Pharmaceutical (WST) position steady in Q2 2026 at 111 shares worth $39.8K. The position accounts for 0.01% of the portfolio, ranked #396.

City State Bank first reported a position in WST in Q4 2021 and has held it in 19 quarters since. The position peaked at $147K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • City State Bank held 111 shares of West Pharmaceutical worth $39.8K as of Q2 2026.
  • City State Bank left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of City State Bank's portfolio in Q2 2026, its #396 holding.
  • City State Bank first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • City State Bank's West Pharmaceutical position peaked at $147K in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.